Duke Clinical Research Institute

April 2, 2020

Study aims to shield health workers from COVID-19 infection

VUMC is playing a key role in a national effort to establish a registry of U.S. health care workers and test whether the anti-malarial drug hydroxychloroquine (HCQ) will protect them, their patients and their families from COVID-19.

By Bill Snyder
speed bump sign
July 5, 2016

New NIH-funded center to study inefficiencies in clinical trials

Researchers at Vanderbilt University Medical Center and Duke Clinical Research Institute have received a major federal grant to study how multisite clinical trials of new drugs and therapies in children and adults can be conducted more rapidly and efficiently.

By Bill Snyder